Immatics (IMTX) Cash & Current Investments (2019 - 2025)
Immatics (IMTX) posted Cash & Current Investments of $546.3 million for Q4 2025, up 8.47% sequentially from $503.7 million in Q3 2025, and down 15.42% YoY from $645.9 million in Q4 2024.
Immatics (IMTX) Cash & Current Investments (2019 - 2025) Analysis & Trends
Immatics has reported Cash & Current Investments for 7 years, with the latest figure at $546.3 million in Q4 2025.
- Quarterly Cash & Current Investments fell 15.42% year-over-year to $546.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $546.3 million (down 15.42% YoY) and the FY2025 annual result came in at $530.3 million, down 18.95% from the prior year.
- Cash & Current Investments rose to $546.3 million in Q4 2025 per IMTX's latest filing, from $503.7 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $645.9 million in Q4 2024 and troughed at $166.0 million in Q4 2021.
- A 5-year average of $415.8 million and a median of $398.4 million in 2023 frame the typical range for Cash & Current Investments.
- The widest YoY moves for Cash & Current Investments: up 144.96% in 2021, down 39.98% in 2021.
- Over 5 years, Cash & Current Investments stood at $166.0 million in 2021, then jumped by 122.6% to $369.5 million in 2022, then rose by 24.0% to $458.2 million in 2023, then jumped by 40.96% to $645.9 million in 2024, then slipped by 15.42% to $546.3 million in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $546.3 million, $503.7 million, and $541.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 836.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.16 Bn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | 546.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 546.33 Mn |
| Sep 30, 2025 | 503.67 Mn |
| Jun 30, 2025 | 541.29 Mn |
| Mar 31, 2025 | 571.97 Mn |
| Dec 31, 2024 | 645.91 Mn |
| Sep 30, 2024 | 538.70 Mn |
| Jun 30, 2024 | 571.94 Mn |
| Mar 31, 2024 | 612.65 Mn |
| Dec 31, 2023 | 458.24 Mn |
| Sep 30, 2023 | 398.45 Mn |
| Jun 30, 2023 | 398.26 Mn |
| Mar 31, 2023 | 354.00 Mn |
| Dec 31, 2022 | 369.54 Mn |
| Sep 30, 2022 | 311.89 Mn |
| Jun 30, 2022 | 346.13 Mn |
| Mar 31, 2022 | 283.66 Mn |
| Dec 31, 2021 | 166.01 Mn |
| Sep 30, 2021 | 204.27 Mn |
| Jun 30, 2021 | 232.19 Mn |
| Mar 31, 2021 | 261.34 Mn |